The success of Sildenafil initially drove a boom for the drug industry, however recent developments present a murky picture for those considering a stake. Off-patent alternatives are reducing revenue, and persistent https://gretalweu257826.thenerdsblog.com/47283500/the-blue-pill-and-the-pharmaceutical-industry-a-volatile-bet